- Founded
- 2016
- Business Model
- B2B
- Website
- reparerx.com
- Total Funding
- $150.5M
- Last Round
- $82.5M Series BSep 2019
- Rounds
- 2
- Type
- Public
About
A precision oncology company developing highly targeted cancer therapies focused on genomic instability and DNA damage repair through synthetic lethality.
Summary
Repare Therapeutics is a Biotech company based in Canada, founded in 2016. It has raised $150.5M in total across 2 rounds, most recently a $82.5M Series B round in Sep 2019. Investors include Jerel Davis, Cowen Healthcare Investments and OrbiMed.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform